GUERRIERI, SIMONE
 Distribuzione geografica
Continente #
EU - Europa 121
NA - Nord America 89
AS - Asia 45
Totale 255
Nazione #
US - Stati Uniti d'America 87
SE - Svezia 49
IT - Italia 43
CN - Cina 24
SG - Singapore 14
RU - Federazione Russa 11
FI - Finlandia 7
FR - Francia 4
IE - Irlanda 3
CA - Canada 2
GB - Regno Unito 2
IR - Iran 2
PK - Pakistan 2
HK - Hong Kong 1
IN - India 1
KR - Corea 1
NL - Olanda 1
RO - Romania 1
Totale 255
Città #
Shanghai 16
Ashburn 13
Boardman 13
Milan 11
Lawrence 10
Princeton 10
Singapore 9
New York 8
Moscow 6
Helsinki 5
Pisa 4
Dublin 3
Rome 3
Washington 3
Columbia 2
Dallas 2
Dalmine 2
Edinburgh 2
Forlì 2
Gujar Khan 2
Lappeenranta 2
Missaglia 2
Parma 2
Saint-Fons 2
Turin 2
Alexandria 1
Elmendorf 1
Isfahan 1
Lyon 1
Ploieşti 1
Pune 1
Rieti 1
San Diego 1
Seattle 1
Shenzhen 1
Toronto 1
Trois-Rivières 1
Utrecht 1
Wuxi 1
Totale 150
Nome #
The visual pathway as a platform to assess demyelination and neurodegeneration in multiple sclerosis: the paradigms of acute optic neuritis and progressive course 49
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 32
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 27
U-Fiber Leukoencephalopathy Due to a Novel Mutation in the TACO1 Gene 27
Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience 22
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 19
Sensitivity and predictive role of OCT and VEP in multiple sclerosis 17
Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography 17
In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis 17
Optical Coherence Tomography and Visual Evoked Potentials as Prognostic and Monitoring Tools in Progressive Multiple Sclerosis 14
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 13
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series 10
Fast but not furious: Rapid ocrelizumab infusion as a strategy to optimize multiple sclerosis patients' management 9
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics 7
Totale 280
Categoria #
all - tutte 2.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 2 1 0 0
2020/20211 0 0 0 0 0 0 0 0 1 0 0 0
2021/202226 1 1 0 8 1 0 2 2 3 0 5 3
2022/2023103 26 22 11 1 1 8 5 7 7 3 2 10
2023/2024109 0 5 13 8 15 17 1 19 3 0 6 22
2024/202538 23 15 0 0 0 0 0 0 0 0 0 0
Totale 280